Oxford Asset Management’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-113,754
| Closed | -$1.89M | – | 2017 |
|
|
2017
Q3 | $1.89M | Buy |
113,754
+4,463
| +4% | +$72.6K | 0.04% | 646 |
|
|
2017
Q2 | $1.96M | Buy |
109,291
+59,365
| +119% | +$1.11M | 0.04% | 626 |
|
|
2017
Q1 | $1M | Sell |
49,926
-86,717
| -63% | -$2.02M | 0.02% | 806 |
|
|
2016
Q4 | $3.42M | Sell |
136,643
-37,360
| -21% | -$883K | 0.12% | 170 |
|
|
2016
Q3 | $4.07M | Buy |
174,003
+29,816
| +21% | +$701K | 0.13% | 192 |
|
|
2016
Q2 | $2.88M | Buy |
144,187
+65,119
| +82% | +$1.22M | 0.1% | 287 |
|
|
2016
Q1 | $1.34M | Buy |
+79,068
| New | +$1.62M | 0.04% | 442 |
|
|
2015
Q4 | – | Sell |
-44,283
| Closed | -$751K | – | 1015 |
|
|
2015
Q3 | $751K | Sell |
44,283
-79,300
| -64% | -$1.23M | 0.02% | 449 |
|
|
2015
Q2 | $1.7M | Sell |
123,583
-36,655
| -23% | -$487K | 0.05% | 371 |
|
|
2015
Q1 | $2.19M | Buy |
160,238
+6,933
| +5% | +$80K | 0.06% | 344 |
|
|
2014
Q4 | $1.62M | Sell |
153,305
-110,115
| -42% | -$1.3M | 0.04% | 419 |
|
|
2014
Q3 | $3.29M | Buy |
263,420
+115,387
| +78% | +$1.61M | 0.08% | 266 |
|
|
2014
Q2 | $2.05M | Buy |
148,033
+130,083
| +725% | +$1.7M | 0.07% | 373 |
|
|
2014
Q1 | $217K | Sell |
17,950
-183,093
| -91% | -$2.1M | 0.01% | 589 |
|
|
2013
Q4 | $2.47M | Sell |
201,043
-8,958
| -4% | -$105K | 0.06% | 381 |
|
|
2013
Q3 | $2.14M | Sell |
210,001
-35,281
| -14% | -$330K | 0.05% | 436 |
|
|
2013
Q2 | $2.2M | Buy |
+245,282
| New | +$2.47M | 0.06% | 448 |
|
Oxford Asset Management's OME Position: Q4 2017 in Review
Oxford Asset Management sold out of Omega Protein (OME) in Q4 2017, closing a stake of 113,754 shares — an estimated $1.89M sold.
Oxford Asset Management first reported a position in OME in Q2 2013 and held it in 17 quarters. The position peaked at $4.07M in Q3 2016. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- Oxford Asset Management reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- Oxford Asset Management sold 113,754 Omega Protein shares in Q4 2017, an estimated $1.89M.
- Oxford Asset Management first reported a position in Omega Protein in Q2 2013 and held it in 17 quarters.
- Oxford Asset Management's Omega Protein position peaked at $4.07M in Q3 2016.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on Oxford Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.